Synta Pharmaceuticals (SNTA) is a biopharmaceutical company focused on discovering, developing and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. This stock is trading up 6.7% to $8.23 in recent trading.
Today's Range: $7.71-$8.2452-Week Range: $3.02-$8.04 Volume: 294,000 Three-Month Average Volume: 904,392 >>5 Big Stocks Ready to Slingshot Higher From a technical perspective, SNTA is soaring higher here right off some near-term support at $7.70 with light volume. This move is quickly pushing SNTA within range of triggering a major breakout trade. That trade will hit once SNTA manages to clear some overhead resistance levels at $8.21 to $8.50 with high volume. Traders should now look for long-biased trades in SNTA as long as it's trending above $7.70, and then once it sustains a move or close above those breakout levels with volume that's near or above 904,392 shares. If that breakout hits soon, then look for SNTA to tag $10 in the near future.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts